ID | 条目 | 数目 | P-Value |
hsa04260 | Cardiac muscle contraction | 12 | 2.90e−011 |
# | Circulatory system | 18 | 2.42e−010 |
hsa00190 | Oxidative phosphorylation | 13 | 1.39e−009 |
# | Energy metabolism | 13 | 1.36e−008 |
# | Neurodegenerative diseases | 17 | 1.08e−007 |
hsa04932 | Non-alcoholic fatty liver disease (NAFLD) | 11 | 6.01e−007 |
# | Endocrine and metabolic diseases | 13 | 1.37e−006 |
# | Endocrine system | 20 | 2.67e−005 |
hsa04911 | Insulin secretion | 7 | 3.82e−005 |
hsa03320 | PPAR signaling pathway | 6 | 9.76e−005 |
hsa04913 | Ovarian Steroidogenesis | 5 | 2.18e−004 |
# | Lipid metabolism | 12 | 6.71e−004 |
hsa04976 | Bile secretion | 5 | 1.09e−003 |
hsa01212 | Fatty acid metabolism | 4 | 1.79e−003 |
hsa04961 | Endocrine and other factor-regulated calcium reabsorption | 4 | 1.79e−003 |